Abu Dhabi Stem Cells Centre and Pluristem Therapeutics Inc. signed an MoU
The Abu Dhabi Stem Cells Centre (ADSSC) has signed a MoU with Israeli firm Pluristem Therapeutics Inc. to collaborate on R&D of services and products related to regenerative medicine, including those that can be used to combat the Covid-19 pandemic
With this collaboration, both the UAE and Israel will rely on the expertise of each other in cell therapies to deliver solutions around regenerative medicine.
ADSSC and Pluristem will exchange research results, share samples, join usage of equipment and testing, and other essential activities related to advancing the treatment and research of cell therapies.
“We are extremely proud to partner with our colleagues at ADSCC by sharing knowledge and expertise that will advance healthcare within and across our borders. We see life science and regenerative medicine as a bridge for building peace, prosperity, and well-being in our region and for the entire world,” said Yaki Yanai, CEO and president of Pluristem.
Proud of the UAE and everything it does to advance the countries ❤
Comments
Post a Comment